Results 101 to 110 of about 1,745,918 (176)

The pseudouridine synthase PUS7 is associated with stemness and represents a potential therapeutic target in triple-negative breast cancer cells. [PDF]

Sci Rep
Lu L, Xue L, Jiang S, He G, Deng X.
europepmc   +1 more source

Systematic benchmarking of dorado basecalling models for RNA modification detection with highly multiplexed nanopore sequencing. [PDF]

Nucleic Acids Res
Diensthuber G, Milenkovic I, Llovera L, Milovanovic A, Pelizzari F, Novoa EM.   +5 more
europepmc   +1 more source

PUS1 Drives Renal Cancer Progression by Preventing Formation of Endogenous Double-stranded RNAs. [PDF]

Int J Biol Sci
Zhu Z, Lu Z, Li F, Xu Z, Wang R, Li Y, Lu H, Ding Y, Luo W, Lin Y, Lu Y, Mao X, Li M, Wang Z, Ding L, Xia L, Li G.   +16 more
europepmc   +1 more source

Synthetic DNA vaccine platform elicits potent immunity where electroporated naked-mRNA is non-immunogenic. [PDF]

J Immunother Cancer
Tonini C, Bianchi A, Esposito M, Esposito I, Giacomelli T, Young E, Lanckriet H, Whiffen Z, Pavlickova M, Entiriwaa D, Principato E, Roscilli G, Piconese S, Lione L, Salvatori E, Pinto E, Ciliberto G, Aurisicchio L, Walker A, Palombo F.   +19 more
europepmc   +1 more source

Dogme: a nextflow pipeline for reprocessing nanopore RNA and DNA modifications. [PDF]

Bioinformatics
Abdollahzadeh E, Mortazavi A.
europepmc   +1 more source

Interprotomer communication and functional asymmetry in H/ACA snoRNPs. [PDF]

Proc Natl Acad Sci U S A
Panwar HS, Vos TJ, Xie X, Jang HJ, Lee H, Sheldon RD, Worden EJ, Kothe U.   +7 more
europepmc   +1 more source

Pseudouridine synthase PUS1 and initiation factor mtIF2 are human mitoribosomal small subunit assembly factors. [PDF]

Nat Commun
Singh V, Shiriaev D, Bilalli L, Khawaja A, Rorbach J.   +4 more
europepmc   +1 more source

RNA-triggered innate immunity: friend and foe. [PDF]

Front Genet
Henschel M, Conte MR, Martinez-Nunez RT.
europepmc   +1 more source

RNA modifications in cancer and their detection: a review. [PDF]

Jpn J Clin Oncol
Yu BY, Ueda H.
europepmc   +1 more source

DKC1: a robust prognostic factor and potential therapeutic target in multiple myeloma. [PDF]

J Transl Med
Sun C, Cheng L, Li A, Han Y, Wang Y, Xiao J, Guo Y, Zhang W, Sun L, Xu D, Kong D, Jiang Y, Zheng C.   +12 more
europepmc   +1 more source